Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology
暂无分享,去创建一个
Jian Zhang | Huihui Zhao | Wei Wang | Kuo Gao | Jianxin Chen | Ghulam Murtaza | Jianxin Chen | Huihui Zhao | Wei Wang | G. Murtaza | Jian Zhang | Feilong Zhang | Kuo Gao | Hua Xie | Jinping Wang | Shaojing Li | Ran Yang | Zhiyong Wang | Caixia Jia | Feilong Zhang | Shaojing Li | Jinping Wang | Hua Xie | Zhiyong Wang | Caixia Jia | Ran Yang
[1] G. Molin,et al. Gut Microbiota and Inflammation , 2011, Nutrients.
[2] J. Shaw,et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.
[3] Jiang He,et al. Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.
[4] Wei Wang,et al. Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism , 2016, Scientific Reports.
[5] S. Keinänen-Kiukaanniemi,et al. Insulin resistance is associated with altered amino acid metabolism and adipose tissue dysfunction in normoglycemic women , 2016, Scientific Reports.
[6] M. Gonthier,et al. Anti‐inflammatory and antioxidant effects of polyphenols extracted from Antirhea borbonica medicinal plant on adipocytes exposed to Porphyromonas gingivalis and Escherichia coli lipopolysaccharides , 2017, Pharmacological research.
[7] Junsong Wang,et al. NMR-based metabonomic study of Chinese medicine Gegen Qinlian Decoction as an effective treatment for type 2 diabetes in rats , 2013, Metabolomics.
[8] C. Knauf,et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.
[9] Sunghoon Kim,et al. Aminoacyl tRNA synthetases and their connections to disease , 2008, Proceedings of the National Academy of Sciences.
[10] Jing Li,et al. The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model , 2009, Experimental diabetes research.
[11] T. Butler,et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. , 1987, The Journal of infectious diseases.
[12] P. Landa,et al. Anti‐inflammatory activity of natural stilbenoids: A review , 2017, Pharmacological research.
[13] Robert A. Rizza,et al. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.
[14] Robert A Rizza,et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.
[15] V. Steele,et al. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. , 2013, Translational oncology.
[16] Liangcai Zhao,et al. Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy. , 2012, Journal of ethnopharmacology.
[17] P. Sansonetti,et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment , 2011, EMBO molecular medicine.
[18] D. Kasper,et al. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. , 2010, Frontiers in bioscience.
[19] I. Martínez,et al. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. , 2010, International journal of food microbiology.
[20] K. Petry,et al. The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry. , 1998, Trends in genetics : TIG.
[21] J. Mazurkiewicz,et al. Leucine Stimulates Insulin Secretion via Down-regulation of Surface Expression of Adrenergic α2A Receptor through the mTOR (Mammalian Target of Rapamycin) Pathway , 2012, The Journal of Biological Chemistry.
[22] Masayuki Orimo,et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance , 2009, Nature Medicine.
[23] Wei Zhou,et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.
[24] Jianxin Chen,et al. Large-scale exploration and analysis of drug combinations , 2015, Bioinform..
[25] Yanjiang Qiao,et al. Mechanism of action of salvianolic acid B by module-based network analysis. , 2014, Bio-medical materials and engineering.
[26] B. Honig,et al. Structure-based prediction of protein-protein interactions on a genome-wide scale , 2012, Nature.
[27] Sarath Chandra Janga,et al. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. , 2009, Molecular bioSystems.
[28] S. Sørensen,et al. Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.
[29] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[30] M. Murphy,et al. The role of the p53 tumor suppressor in metabolism and diabetes. , 2016, The Journal of endocrinology.
[31] J. Calviño,et al. Insulin resistance and the metabolism of branched-chain amino acids in humans , 2011, Amino Acids.
[32] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[33] Mi-Kyung Sung,et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in Diet-Induced Obese Mice Is Associated with Gut Microbial Changes and Reduction in Obesity , 2013, PloS one.
[34] J. Shaw,et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.
[35] S. Tsao,et al. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. , 2009, Journal of ethnopharmacology.
[36] Na-Ri Shin,et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice , 2013, Gut.
[37] Xin Yao,et al. Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network , 2011, BMC Systems Biology.
[38] Liping Zhao,et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula , 2014, The ISME Journal.
[39] G. Ning,et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.
[40] J. Ferrières,et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.
[41] S. Sookoian,et al. Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome. , 2012, World journal of gastroenterology.
[42] L. Zhihong,et al. Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia , 2016, Scientific Reports.
[43] Damian Szklarczyk,et al. STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..
[44] Liping Zhao. The gut microbiota and obesity: from correlation to causality , 2013, Nature Reviews Microbiology.
[45] A. Kristal,et al. The carbon isotope ratio of alanine in red blood cells is a new candidate biomarker of sugar-sweetened beverage intake. , 2013, The Journal of nutrition.
[46] Lehui Lu,et al. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids , 2010, Nanotechnology.
[47] Xi-jun Wang,et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. , 2011, Journal of pharmaceutical and biomedical analysis.
[48] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[49] M. Li,et al. Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats , 2012, PloS one.
[50] W-M Tian,et al. Formononetin exhibits anti-hyperglycemic activity in alloxan-induced type 1 diabetic mice , 2017, Experimental biology and medicine.
[51] Liping Zhao,et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome , 2013, FEMS microbiology ecology.
[52] Khin-Maung-U,et al. Clinical trial of berberine in acute watery diarrhoea. , 1985, British medical journal.
[53] Haiyuan Yang,et al. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling. , 2016, Molecular endocrinology.
[54] Liping Zhao,et al. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice , 2012, The ISME Journal.
[55] Jingjing Xu,et al. Metabolomic Profiling of Serum from Human Pancreatic Cancer Patients Using 1H NMR Spectroscopy and Principal Component Analysis , 2011, Applied biochemistry and biotechnology.
[56] Dongwei Zhang,et al. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety , 2017, Pharmacological research.
[57] Jun Ren,et al. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. , 2007, Current diabetes reviews.
[58] V. Sychareun,et al. Adherence to Antiretroviral Therapy (ART) among People Living With HIV (PLHIV): a cross-sectional survey to measure in Lao PDR , 2013, BMC Public Health.
[59] Xiang Wang,et al. Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3β signaling pathway. , 2016, Biochemical and biophysical research communications.